Surrozen (SRZN) Current Assets (2020 - 2026)
Surrozen (SRZN) recorded quarterly Current Assets of $113.9 million in Q1 2026, up 24.45% quarter-over-quarter from $91.6 million in Q4 2025, and up 7.49% on a YoY basis from $106.0 million in Q1 2025.
Surrozen (SRZN) Current Assets (2020 - 2026) Analysis & Trends
Surrozen's Current Assets history runs 7 years deep, the most recent figure standing at $113.9 million for Q1 2026.
- In Q1 2026, Current Assets rose 7.49% year-over-year to $113.9 million; the TTM figure through Mar 2026 stood at $113.9 million (up 7.49% YoY), while the FY2025 annual figure was $91.6 million, up 135.18% from the prior year.
- Current Assets was $113.9 million for Q1 2026 at Surrozen, up from $91.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $113.9 million in Q1 2026 to a low of $32.0 million in Q1 2024.
- Historically, Current Assets has averaged $71.7 million across 5 years, with a median of $81.3 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Current Assets surged 10234.74% in 2022, then slumped 52.24% in 2024.
- A 5-year view of Current Assets shows it stood at $81.3 million in 2022, then slumped by 49.41% to $41.1 million in 2023, then declined by 5.35% to $38.9 million in 2024, then soared by 135.18% to $91.6 million in 2025, then advanced by 24.45% to $113.9 million in 2026.
- The last three Current Assets figures came in at $113.9 million (Q1 2026), $91.6 million (Q4 2025), and $85.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 600.85 Mn |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - | 113.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 113.95 Mn |
| Dec 31, 2025 | 91.56 Mn |
| Sep 30, 2025 | 85.86 Mn |
| Jun 30, 2025 | 94.24 Mn |
| Mar 31, 2025 | 106.01 Mn |
| Dec 31, 2024 | 38.93 Mn |
| Sep 30, 2024 | 45.29 Mn |
| Jun 30, 2024 | 41.64 Mn |
| Mar 31, 2024 | 32.02 Mn |
| Dec 31, 2023 | 41.13 Mn |
| Sep 30, 2023 | 48.36 Mn |
| Jun 30, 2023 | 57.58 Mn |
| Mar 31, 2023 | 67.03 Mn |
| Dec 31, 2022 | 81.31 Mn |
| Sep 30, 2022 | 82.72 Mn |
| Jun 30, 2022 | 94.82 Mn |
| Mar 31, 2022 | 95.68 Mn |
| Dec 31, 2021 | 105.19 Mn |
| Sep 30, 2021 | 114.00 Mn |
| Jun 30, 2021 | 917,478.00 |